Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)

INTRODUCTION: Bardoxolone methyl significantly increases estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD). However, the phase 3 study, Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: the Occurrence of Renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Nangaku, Masaomi, Kanda, Hironori, Takama, Hirotaka, Ichikawa, Tomohiro, Hase, Hiroki, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271944/
https://www.ncbi.nlm.nih.gov/pubmed/32518870
http://dx.doi.org/10.1016/j.ekir.2020.03.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271944/
https://www.ncbi.nlm.nih.gov/pubmed/32518870
http://dx.doi.org/10.1016/j.ekir.2020.03.030

Ejemplares similares